title: Characteristics of Maternal-Infant Interaction During Treatment for Opioid Withdrawal.
abstract: OBJECTIVE
  The purpose of this study was to describe the interactions between mothers in a methadone treatment program and their infants during a bottle feeding and compare the findings with normed data.
  
  
  METHODS
  A comparative-descriptive design was used.
  
  
  METHODS
  Data from 12 opiate-exposed mother-infant dyads were compared with normed data.
  
  
  METHODS
  Nursing Child Assessment Satellite-Training Scale scores.
  
  
  RESULTS
  The opiate-exposed dyads scored significantly lower than the normed dyads in the infant subscales of clarity of cues (p < .001, 95% confidence interval [CI], 1.56-4.08) and responsiveness to caregiver (p < .01, 95% CI, 0.27-2.5), as well as the total score (p < .001, 95% CI, 2.42-6.15). Parent sensitivity to infant cues subscale (p < .01, 95% CI, 0.42-2.37) and parent contingency score (p < .01, 95% CI, 0.55-3.81) were also significantly lower. The cognitive growth fostering subscale scores were significantly higher in the neonatal abstinence syndrome (NAS) group (p < .01, 95% CI,- 2.94 to- 0.7).
authors.affiliation: University of South Florida College of Nursing.
authors.forename: Denise J
authors.initials: DJ
authors.lastname: Maguire
authors.forename: Susan
authors.initials: S
authors.lastname: Taylor
authors.forename: Kathleen
authors.initials: K
authors.lastname: Armstrong
authors.forename: Emily
authors.initials: E
authors.lastname: Shaffer-Hudkins
authors.forename: Rita
authors.initials: R
authors.lastname: DeBate
authors.forename: Aaron M
authors.initials: AM
authors.lastname: Germain
authors.forename: Sandra S
authors.initials: SS
authors.lastname: Brooks
mesh_terms: D000293:Adolescent; D000328:Adult; D001903:Bottle Feeding / Q000523:psychology*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D009034:Mother-Child Relations / Q000523:psychology*; D009294:Narcotics / Q000009:adverse effects; D009357:Neonatal Abstinence Syndrome / Q000188:drug therapy / Q000523:psychology*; D058850:Opiate Substitution Treatment; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000523:psychology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000523:psychology; D055815:Young Adult
chemical_list: D009294:Narcotics; D008691:Methadone